Hormones

Hormones, subtitled International Journal of Endocrinology and Metabolism, is the quarterly journal of the Hellenic Endocrine Society, published by Springer, and it has covered clinical and experimental endocrinology since 2002. Its 2025 Journal Impact Factor is 2.4, and the five-year figure is 2.7.《激素》是希腊内分泌学会（Hellenic Endocrine Society）的会刊，由 Springer 出版，刊名之下另排副标题（International Journal of Endocrinology and Metabolism），2002 年创刊，覆盖临床与实验内分泌学。2025 年期刊影响因子为 2.4，五年影响因子为 2.7。

Scope

• The aims page frames an international quarterly with an international editorial board, and its remit takes in the whole of endocrinology and metabolic disease.宗旨页把刊物定位为一年四期的国际期刊，编委由各国学者组成，取材范围覆盖内分泌与代谢病的全部领域。

• Four groups of disorders anchor the remit, the first being disruption of glucose homeostasis, which the editors gloss as diabetes mellitus.四组疾病划定这一范围，第一组是葡萄糖稳态紊乱，官网注明即糖尿病。

• Impaired homeostasis of plasma lipids, glossed as dyslipidemia, comes next, and disorders of bone metabolism such as osteoporosis follow.随后是血浆脂质稳态受损，即血脂异常，再往后是骨质疏松一类骨代谢紊乱。

• Disturbances of endocrine function and of reproductive capacity in women and men make up the fourth group.第四组是女性与男性内分泌功能及生殖能力的障碍。

• Clinical, translational and basic science submissions are invited in endocrine cancers, where tumour biology meets hormone secretion and signalling.内分泌肿瘤方向征集临床、转化与基础研究稿件，肿瘤生物学与激素分泌及信号传递在此交汇。

• Nutrition, obesity and metabolic disorders form a further priority, and studies of the quality of life of endocrine patients sit beside them.营养、肥胖与代谢病是另一个优先方向，内分泌患者生活质量的研究与它们并列。

• Epidemiology of endocrine and metabolic disorders is named in the same paragraph, and the journal keeps a separate article type for it.内分泌与代谢病的流行病学也在同一段里列出，刊物为它单设一类稿件。

• A second stated purpose is educational, since expert reviews are commissioned to keep knowledge current, and young investigators are named as the readers that strand chiefly serves.宗旨另写明一项教育作用，编辑部约请专家综述以更新知识，并称这条线索主要面向年轻研究者。

• Reviews of the literature, original research on humans or experimental animals, and translational research account for most of what appears.文献综述、以人体或实验动物为对象的原创研究以及转化研究，占据刊物内容的大半。

• Editorial commentaries on papers already published and letters to the editor about important new developments complete the list of research forms.针对已刊论文的编辑评论以及围绕重要新进展致编辑的信，补齐了研究类体裁的清单。

• History of endocrinology and PROS & CONS in Endocrinology are named categories, and each carries its own length rule.内分泌史与 PROS & CONS in Endocrinology 都是具名栏目，各有篇幅规定。

• Case reports are considered only in exceptional circumstances, where a novel mechanism or a mutation not previously described is involved.病例报告只在例外情形下受理，前提是涉及新机制或此前未见描述的突变。

• A review may reach 6,000 words with an abstract of at most 250 words, no more than seven authors, four to six illustrations and 70 to 80 references.综述可至 6000 词，摘要不超过 250 词，作者不超过 7 人，插图 4 至 6 幅，参考文献 70 至 80 条。

• Original articles stop at 5,000 words with a structured abstract near 250 words, and they carry no more than seven authors and 50 references.原创论文以 5000 词为限，附约 250 词的结构式摘要，作者不超过 7 人，参考文献不超过 50 条。

• Shorter formats pair the 4,000-word short review with the 2,000-word rapid communication, whose structured abstract is capped at 150 words.短篇格式把 4000 词的短综述与 2000 词的快速通讯配成一组，后者的结构式摘要以 150 词为上限。

• Letters take 800 words, commentaries 500, book reviews 1,000, guidelines and position statements up to 6,000 with 60 to 70 references, and brief genetic reports 500 with one table and one figure.信稿限 800 词，评论 500 词，书评 1000 词，指南与立场声明可至 6000 词并附 60 至 70 条参考文献，遗传学简报 500 词并配 1 表 1 图。

History

• The journal was founded in 2002 as the official publication of the Hellenic Endocrine Society, a society established in 1964, so the two dates belong to different bodies.刊物于 2002 年创刊，作为希腊内分泌学会的会刊，该学会成立于 1964 年，两个年份分属不同主体。

• Volume numbering supports that start, since the June 2026 issue is volume 25, issue 2, which places the first volume in 2002.卷号可以印证这一点，2026 年 6 月一期为第 25 卷第 2 期，首卷正落在 2002 年。

• SpringerLink holdings begin with volume 7 in 2008, and the journal page points readers to hormones.gr for volumes 1 to 6.SpringerLink 的馆藏从 2008 年第 7 卷起，前六卷的入口指向学会站点 hormones.gr。

• Issues came out in January, April, July and October through volume 16 in 2017, and from volume 17 in 2018 the months moved to March, June, September and December.第 16 卷（2017 年）及以前，各期在 1 月、4 月、7 月与 10 月出版，第 17 卷（2018 年）起改为 3 月、6 月、9 月与 12 月。

• The library imprint moved in 2018 from Athens, where the society published, to Cham and Springer International Publishing, a change of distributor and calendar rather than a second founding.馆藏记录的出版项也在 2018 年从学会所在的雅典转到 Springer International Publishing（Cham），属于发行方与出刊月份的更替，并非另一次创刊。

• Print ISSN 1109-3099 and electronic ISSN 2520-8721 mark the two formats, and both are registered to the same editorial owner.纸本 ISSN 为 1109-3099，电子版为 2520-8721，两种载体登记在同一编辑部名下。

• The publishing model is hybrid, so authors may stay on the subscription route or pay for Open Choice, and 139 open access articles are listed on the platform.出版模式为混合型，作者可留在订阅路线，也可选择 Open Choice 开放获取并承担相应费用，平台上列出的开放获取文章已有 139 篇。

• Copyright on the journal page rests with the Hellenic Endocrine Society, and Springer handles distribution.刊物页面的版权署名是希腊内分泌学会，发行由 Springer 承担。

• MEDLINE began indexing the title with volume 4, number 1, in the first quarter of 2005, and Science Citation Index Expanded lists it too.MEDLINE 自 2005 年第一季度的第 4 卷第 1 期起收录，Science Citation Index Expanded 同样收录。

• The 2025 Journal Impact Factor is 2.4 against a five-year value of 2.7, with 2,377 citations, 71 articles a year and a cited half-life of 5.8 years.2025 年期刊影响因子为 2.4，五年值为 2.7，总被引 2377 次，年发文 71 篇，被引半衰期 5.8 年。

• Readers downloaded 421.7 thousand articles in 2025, and the median wait from submission to a first decision is 22 days.2025 年文章下载量为 42.17 万次，投稿到首次决定的中位时间为 22 天。

• In the 2025 Journal Citation Reports the title sits in Endocrinology and Metabolism, ranked 135th of 198 and placed in Q3.2025 年期刊引证报告把该刊归入内分泌与代谢类，在 198 种期刊中排第 135 位，落在 Q3。

• Historical Notes and Notes on Etymology of Medical Terms run as recurring special sections, and corrected proofs appear as Online First with a citable DOI before any print issue.Historical Notes 与 Notes on Etymology of Medical Terms 是特设栏目，校样定稿后先以 Online First 上线，附可引用的 DOI，再编入纸本。

Editors

• Constantine A. Stratakis holds the editor-in-chief post, with affiliations at Elpen Pharmaceutical in Athens, the FORTH Institute of Molecular Biology and Biotechnology in Heraklion, Henry Dunant Hospital and the National Institutes of Health in Bethesda.主编为（Constantine A. Stratakis），同时在雅典的 Elpen Pharmaceutical、伊拉克利翁的 FORTH Institute of Molecular Biology and Biotechnology、Henry Dunant Hospital 与贝塞斯达的 National Institutes of Health 任职。

• Three deputy editors-in-chief assist the editor-in-chief, Dimitrios G. Goulis and Stergios A. Polyzos of Aristotle University of Thessaloniki, and Paraskevi Xekouki of the University of Crete.三位副主编协助主编工作，即 Aristotle University of Thessaloniki 的（Dimitrios G. Goulis）与（Stergios A. Polyzos），以及 University of Crete 的（Paraskevi Xekouki）。

• Stavroula A. Paschou is an associate editor and directs communications and Hormones News from the National and Kapodistrian University of Athens.副编辑（Stavroula A. Paschou）兼任传播事务与 Hormones News 主管，任职于 National and Kapodistrian University of Athens。

• Jihad Adel Haddad covers the Middle East as overseas editor, working from the Ministry of Health in Amman, Jordan.海外编辑（Jihad Adel Haddad）负责中东地区，供职于约旦安曼的 Ministry of Health。

• Fifty-two associate editors and forty-seven editorial board members carry the disciplinary range, and two honorary members sit above them.52 位副编辑与 47 位编委承担各学科方向，另设 2 位名誉委员。

• The honorary board is made up of Catherine Dacou-Voutetakis of the National and Kapodistrian University of Athens and Andre N. Margioris of the University of Crete.名誉委员为 National and Kapodistrian University of Athens 的（Catherine Dacou-Voutetakis）与 University of Crete 的（Andre N. Margioris）。

• The roster runs to 109 people from 18 countries, Greek institutions supplying the largest share, with members also in Jordan, Egypt, the United States, Germany, Italy, Denmark, Sweden and the United Kingdom.名单合计 109 人，来自 18 个国家，希腊机构占多数，其余成员分布在约旦、埃及、美国、德国、意大利、丹麦、瑞典与英国。

• Statistics editing falls to Alexandros Gryparis of the University of Crete, and Olga Nikolaou of the Hellenic Endocrine Society manages the secretariat.统计编辑由 University of Crete 的（Alexandros Gryparis）负责，秘书处由希腊内分泌学会的（Olga Nikolaou）管理。

• Greek and overseas posts sit side by side on the roster, which names George P. Chrousos in Athens, Ilpo Huhtaniemi at Imperial College London, Martin Reincke at LMU Munich and Anton Luger at the Medical University of Vienna.希腊与海外职位在名单上并列，其中有雅典的（George P. Chrousos）、Imperial College London 的（Ilpo Huhtaniemi）、LMU Munich 的（Martin Reincke）与 Medical University of Vienna 的（Anton Luger）。

• Further names include Salvatore Minisola at Sapienza University of Rome, Sylvia L. Asa at Case Western Reserve University, Electron Kebebew at Stanford University and Wilmar M. Wiersinga at the University of Amsterdam.名单还包括 Sapienza University of Rome 的（Salvatore Minisola）、Case Western Reserve University 的（Sylvia L. Asa）、Stanford University 的（Electron Kebebew）与 University of Amsterdam 的（Wilmar M. Wiersinga）。

• Review is single blind, as the guidelines state plainly, and the identity of referees is withheld from authors while author names travel with the manuscript.评审采用单盲，指南写明这一点，审稿人身份对作者保密，作者姓名则随稿送审。

• Electronic submission is mandatory, and the editorial office keeps three separate mailboxes for information, the secretariat and the editor.投稿必须走电子系统，编辑部另设三个邮箱，分别处理信息咨询、秘书事务与主编来信。

• Manuscripts must be clear and correct in English, and the editors warn that papers falling short of that standard may be rejected before review.稿件英文必须清晰无误，编辑部提醒不达标的论文可能在送审前被退回。

• Accepted papers are copyedited for style, and the title page requires a structured abstract of 150 to 250 words arranged as purpose and methods, results and conclusion.录用稿会做文字加工，题名页要求 150 至 250 词的结构式摘要，先写目的与方法，再写结果与结论。

• Large language models cannot be listed as authors, their use must be documented in the methods, and the journal follows a type 2 research data policy.大语言模型不能列为作者，使用情况须在方法部分说明，刊物执行第二类研究数据政策。